RxDoctor Payments Data

Kansas St Clair

Family · Lubbock, TXNPI 1457791824

Payments from drug & device makers

$3,060in general payments, 2019–2025

Across 60 payments — averaging $51.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Boston Scientific$793
  • Saluda Medical Americas, Inc.$130
  • Abbott$123
  • Novartis$101
  • Boehringer Ingelheim$45
  • plus $147 from 6 others

What the payments were for

  • Travel & lodging$1,54250%
  • Food & beverage$1,47348%
  • Education$451%

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,060 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$38,285
Medicare patients
263
Services billed
617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban76$61,729
EliquisApixaban78$60,401
EntrestoSacubitril/Valsartan76$57,875
JardianceEmpagliflozin36$28,349
BrilintaTicagrelor37$20,332
FarxigaDapagliflozin Propanediol13$10,816
Repatha SureclickEvolocumab13$6,473
Rosuvastatin Calcium171$2,418
Bumetanide17$1,546
Atorvastatin Calcium147$1,479
Ranolazine ErRanolazine19$1,144
Isosorbide Mononitrate ErIsosorbide Mononitrate81$1,077
Potassium Chloride45$950
Metoprolol Succinate79$833
ClopidogrelClopidogrel Bisulfate75$732

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$101$57,87576 claims
AstraZenecaBrilinta, Farxiga$22$31,14850 claims
Boehringer IngelheimJardiance$45$28,34936 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 15,456 family providers in Texas.

Other family in Lubbock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →